1 ## **The Elizabeth Coteman Fund** ## **Trustees’ Annual Report and Accounts** ## **Year ending March 2025** **Registered Charity Number 1171840** 2 ## **Contents** **1. Reference and Administrative Details** **2. Annual Report of the Trustees** **3. Statement of Financial Activities** 3 ## **1. Reference and Administrative Details** The Trustees who served during the year ended 31 March 2024 were: Emma Lane Gemma Coteman Gerald Coteman – acting Director (unpaid) Laura Coteman Administrator: Julie Moir (unpaid) ## **Registered Office:** 27 Thornton Court Cambridge CB3 0NS ## **Accountants:** Paul Glover Associates Limited Progress House Rowles Way Swavesey Cambridge CB24 4UG ## **Bank:** The Co-operative Bank 1 Balloon Street Manchester M60 4EP 4 ## **2. Annual Report of the Trustees** ## **Objectives:** "The preservation and protection of good health for the public benefit and the relief of need among individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis by: - Offering grants to those groups working with individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis. - Offering grants to NHS clinical pancreatic cancer services where this will directly improve services and support for individuals and families living with a diagnosis of pancreatic cancer or pancreatitis - where funding would not otherwise be available. - Supporting research into pancreatic cancer with selected grants for research teams and pancreatic cancer patients participating in clinical trials and promoting the publication of the useful results of that research. - Raising awareness of pancreatic cancer and its effects. - Providing financial, practical, and emotional support to those diagnosed with pancreatic cancer and their families and carers through appropriate referral and signposting in a way that will improve quality of life. - Working in partnership with other relevant charities and groups to achieve better outcomes for those diagnosed with pancreatic cancer and their families and carers". ## **Overview** ## Activity Last year, the Trustees took the decision to suspend its grant making and transfer funds in the form of an endowment grant to the charity ‘Something To Look Forward To’ (STLFT). Our partnership with that charity has been hugely successful, enabling us to reach patients and families that we may not have reached otherwise. An agreement of terms ensures that the endowment pot will allow grant making by STLFT to last for several years and thus protect the legacy of our founder, Elizabeth Coteman. At the end of the year to March 2025 significant progress had been made by STLFT with regard to gifts and experiences provided for individuals and families faced with the challenge of pancreatic cancer. The action to make the endowment grant was based on our charity holding unnecessarily high reserves and declining grant applications. The arrangement with STLFT is consistent with our overall aims and will do more to directly support quality of life for this patient group than we were able to achieve through our old grants programme. This represents better value for the funds raised over many years by our wonderful supporters. The Elizabeth Coteman Fund will step up its focus on support for patients and families, through advocacy, emotional and bereavement support and problem solving. The charity will also be extending its work in the areas of clinical research and improved patient experience. ## Finance The charity has adequate reserves for its patient support work, although some fundraising will continue. We expect to remain in robust financial health for the foreseeable future. ## **Governance** The Trustees operate a light-touch but robust model of governance to ensure that decisions relating to those we seek to support are made quickly and effectively. Relevant policies and procedures are in place, and followed, to ensure openness, accountability, data protection and relevant compliance. Trustees are also mindful of the Charity Commission’s public benefit test, which is adhered to. 5 ## **Risk** The Trustees have adopted a policy of low exposure to risk and have put in place a risk management framework that covers: - Financial Risk - Operational Risk - Reputational Risk - Compliance Risk There are currently no major risks to report. ## **Performance** Meeting Objectives (by comparison with previous year): **1.** Grants to groups working with individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis – **the same.** 2. Grants to NHS clinical pancreatic cancer services where this will directly improve services and support for individuals and families living with a diagnosis of pancreatic cancer or pancreatitis, and where funding would not otherwise be available – **none.** **3.** Supporting pancreatic cancer research with selected grants for research teams and pancreatic cancer patients participating in clinical trials and publicising the useful results of that research – **no grants this year but increased ‘in-kind’ support.** **4.** Raising awareness of pancreatic cancer and its effects – increased awareness raising, events, public presentations, and media coverage **– the same.** 5. Providing financial, practical, and emotional support to those diagnosed with pancreatic cancer and their families/carers through appropriate referral/signposting to improve quality of life – **numbers of cases remain low but with much higher levels of time input.** **6.** Partnerships with other charities and groups to achieve better outcomes/quality of life for pancreatic cancer patients and their families – **our work with partners continues to increase.** ## **Impact** The Trustees record and analyse feedback on services and support provided. Feedback forms are issued direct and via our partners although, given the nature of pancreatic cancer and its effect on families, it is sometimes difficult to encourage respondents to complete them. However, feedback received is, without exception, positive and values highly the support provided by the Charity. 6 ## **3. Statement of Financial Activities** ## **a) Income & Expenditure** b) Balance Sheet OAXJ 9R9.78 1&12&51 I4￿￿71 1482&71 14W&71 oxo 5932&95 (44SJ3.24) I&Eko>rt 14825.71 **The Elizabeth Coteman Fund CE010444 Receipts and payments accounts For the period 01-Apr-24 31-Mar-25 To from** I ces eee **CC16a** ## **Section A Receipts and payments** |**A1 Receipts**||**Unrestricted**
**funds**
**to the nearest**
**£**|**Unrestricted**
**funds**
**to the nearest**
**£**|**to the nearest**|**Restricted**
**funds**
**to the nearest £**|**Restricted**
**to the nearest £**|||**Endowment**
**funds**
**to the nearest £**|**Endowment**
**funds**
**to the nearest £**|**Endowment**||**Total funds**
**to the nearest £**||**Last year**
**to the nearest £**|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |Donations||**3,739**|**3,739**||**-**|**-**|**-**||**-**|**-**|**-**||**3,739**||**3,725**|| |Grants||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |Fundraising||**1,118**|**1,118**||**-**|**-**|**-**||**-**|**-**|**-**||**1,118**||**-**|| |Transfer from CCF||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |Bank Interest Received||**905**|**905**||**-**|**-**|**-**||**-**|**-**|**-**||**905**||**682**|| |Taxation reclaimed||**1,039**|**1,039**||**-**|**-**|**-**||**-**|**-**|**-**||**1,039**||**400**|| |||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |**_Sub total_**_(Gross income for AR)_|_(Gross income for AR)_|**6,801**|**6,801**||**-**|**-**|**-**||**-**|**-**|**-**||**6,801**||**4,807**|| |**A2 Asset and investment sales,**
**(see table).**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**_Sub total_ -**
**-**
**-**
**-**
**-**
**_Total receipts_**
**6,801**
**-**
**-**
**6,801**
**4,807**
**A3 Payments**
————~~——~~||||||||||||||||| |Grants||**50,600**|**50,600**||**-**|**-**|**-**||**-**|**-**|**-**||**50,600**||**6,850**|| |Fund Raising Expenses||**292**|**292**||**-**|**-**|**-**||**-**|**-**|**-**||**292**||**-**|| |PR and Marketing||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |Travelling, Subsistence and Entertaining||**60**|**60**||**-**|**-**|**-**||**-**|**-**|**-**||**60**||**31**|| |Administration||**149**|**149**||**-**|**-**|**-**||**-**|**-**|**-**||**149**||**260**|| |Sundry||**65**|**65**||**-**|**-**|**-**||**-**|**-**|**-**||**65**||**100**|| |Bank Charges||**139**|**139**||**-**|**-**|**-**||**-**|**-**|**-**||**139**||**13**|| |||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |||**-**|**-**||**-**|**-**|**-**||**-**|**-**|**-**||**-**||**-**|| |**_Sub total_ **||**51,305**|**51,305**||**-**|**-**|**-**||**-**|**-**|**-**||**51,305**||**7,254**|| |**A4 Asset and investment**
**purchases, (see table)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**_Sub total_ -**
**-**
**-**
**-**
**-**
**_Total payments_**
**51,305**
**-**
**-**
**51,305**
**7,254**
**_Net of receipts/(payments)_**
**- 44,503**
**-**
**- - 44,503**
**- 2,447**
**A5 Transfers between funds**
**-**
**- -**
**-**
**-**
**A6 Cash funds last year end**
**59,330**
**- -**
**59,330**
**61,777**
**_Cash funds this year end_**
**14,827**
**-**
**- 14,827**
**59,330**
————~~——~~
===>>||||||||||||||||| CCXX R1 accounts (SS) 29/11/2025 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on behalf
of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
Current Account
Deposit Account
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**5,197**
**-**
**9,630**
**-**
**-**
**-**
**14,827**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name|**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**| |---|---|---|---| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**When due**
**(optional)**
Date of
approval| CCXX R2 accounts (SS) 29/11/2025 2